CORT FY 2025 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$761M+12.8% YoY

Gross Profit

$748M98.3% margin

Operating Income

$45M5.9% margin

Net Income

$100M13.1% margin

EPS (Diluted)

$0.82

Cash Flow

Operating Cash Flow

$142M

Free Cash Flow

$142M

Stock-Based Comp.

$85M

Balance Sheet

Total Assets

$837M

Total Liabilities

$189M

Stockholders' Equity

$648M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$761M	$675M	+12.8%
Gross Profit	$748M	$664M	+12.7%
Operating Income	$45M	$137M	-67.3%
Net Income	$100M	$140M	-28.7%